Vera Therapeutics, Inc.

13.79 USD
+0.09 (+0.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vera Therapeutics, Inc. stock is up 19.81% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 1 PUT, 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Oct 19:19 17 Nov, 2023 10.00 PUT 257 303
10 Nov 19:58 15 Dec, 2023 17.50 CALL 479 540

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for immunoglobulin A nephropathy.

  • JP Morgan
    Thu Nov 30, 14:30
  • Jefferies
    Fri Nov 10, 05:28